Results 231 to 240 of about 164,898 (351)

Opioid consumption after lower limb amputation in Medicare beneficiaries

open access: yesPM&R, EarlyView.
Abstract Background Despite targeted national quality improvement initiatives, opioid prescription and use patterns after lower limb amputation are not well studied. Objective To determine risk factors associated with extended opioid use and rates of high‐risk opioid prescribing after lower limb amputation. Design and setting A retrospective population‐
Alexander N. Khouri   +5 more
wiley   +1 more source

Long‐Term Follow‐Up of Neoadjuvant Enzalutamide Plus Androgen Deprivation Therapy in Localized Prostate Cancer: A Secondary Analysis of a Neoadjuvant Feasibility Trial

open access: yesThe Prostate, EarlyView.
ABSTRACT Introduction Neoadjuvant intense androgen deprivation therapy (ADT) with androgen receptor signaling inhibitors (ARSIs) has shown pathologic complete responses (pCR) in prostate cancer (PCa), but long‐term survival outcomes remain unclear. This study evaluates the durability of response following neoadjuvant ADT plus enzalutamide before robot ...
Braden Millan   +9 more
wiley   +1 more source

Injection Drug Users Trained by Overdose Prevention Programs: Responses to Witnessed Overdoses

open access: green, 2012
Stephen E. Lankenau   +6 more
openalex   +2 more sources

Evaluation of the PK/PD Changes on MASLD‐Related Population—An Example From Simultaneous Acetaminophen Parent‐Metabolite PBPK/PD Modeling

open access: yesCPT: Pharmacometrics &Systems Pharmacology, EarlyView.
ABSTRACT Patients with metabolic dysfunction‐associated steatotic liver disease (MASLD) may exhibit altered pharmacokinetics (PK) and pharmacodynamics (PD) of drugs compared with healthy populations. However, no physiologically based pharmacokinetic/pharmacodynamic (PBPK/PD) model has been specifically developed for MASLD.
Shanshan Zhao, Lan Zhang
wiley   +1 more source

Drug Overdose Deaths Among Medicaid Beneficiaries.

open access: yesJAMA Health Forum
Mark TL, Huber BD.
europepmc   +1 more source

Home - About - Disclaimer - Privacy